FIBROBIOLOGICS INC. - COMMON STOCK

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

05 Feb 2025 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

30 Dec 2024 16:30:00 By Nasdaq GlobeNewswire

FibroBiologics Announces $25 Million Financing

23 Dec 2024 07:55:00 By Nasdaq GlobeNewswire

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

19 Nov 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

14 Nov 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 Nov 2024 16:20:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

29 Oct 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

28 Oct 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

18 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

16 Oct 2024 09:15:00 By Nasdaq GlobeNewswire

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

11 Oct 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

30 Sep 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Engages Southern Star Research as CRO in Australia

19 Sep 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

12 Sep 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

06 Sep 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

20 Aug 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Files 2024 Second Quarter Report

07 Aug 2024 18:52:58 By Nasdaq GlobeNewswire

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

15 Jul 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

25 Jun 2024 09:31:00 By Nasdaq GlobeNewswire

FibroBiologics Set to Join Russell 2000® Index

13 Jun 2024 09:31:00 By Nasdaq GlobeNewswire